{"id":"https://openalex.org/W2955865129","doi":"https://doi.org/10.1111/dom.13822","title":"Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self\u2010titrating insulin glargine U\u2010100","display_name":"Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self\u2010titrating insulin glargine U\u2010100","publication_year":2019,"publication_date":"2019-07-02","ids":{"openalex":"https://openalex.org/W2955865129","doi":"https://doi.org/10.1111/dom.13822","mag":"2955865129","pmid":"https://pubmed.ncbi.nlm.nih.gov/31264764","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6852247"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13822","doi":"https://doi.org/10.1111/dom.13822","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13822","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13822","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13822","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048198396","display_name":"Priscilla A. Hollander","orcid":"https://orcid.org/0000-0003-2072-632X","observed_orcids":["https://orcid.org/0000-0003-2072-632X"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Priscilla A. Hollander","raw_affiliation_strings":["Department of Endocrinology, Baylor Endocrine Center, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Baylor Endocrine Center, Dallas, Texas","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021409500","display_name":"Jacek I. Kiljanski","orcid":"https://orcid.org/0000-0003-0354-0558","observed_orcids":["https://orcid.org/0000-0003-0354-0558"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacek Kiljanski","raw_affiliation_strings":["Department of Diabetes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058916420","display_name":"Erik Spaepen","orcid":"https://orcid.org/0000-0001-7590-7844","observed_orcids":["https://orcid.org/0000-0001-7590-7844"]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Erik Spaepen","raw_affiliation_strings":["Department of Statistics, Eli Lilly Deutschland GmbH, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Statistics, Eli Lilly Deutschland GmbH, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040502478","display_name":"Cynthia J. Harris","orcid":"https://orcid.org/0000-0001-6897-3691","observed_orcids":["https://orcid.org/0000-0001-6897-3691"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia J. Harris","raw_affiliation_strings":["Department of Diabetes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5048198396"],"corresponding_institution_ids":["https://openalex.org/I2802366037"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":1.4201,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.82575634,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"21","issue":"11","first_page":"2413","last_page":"2421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.7821999788284302,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.7821999788284302,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.21089999377727509,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3604","display_name":"Emergency Medical Services"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.871999979019165},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9710000157356262},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9380000233650208},{"id":"https://openalex.org/keywords/self-titration","display_name":"self-titration","score":0.8740000128746033},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.6330000162124634},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.949999988079071},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.6010000109672546},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7279999852180481},{"id":"https://openalex.org/keywords/insulin-naive-patients","display_name":"insulin-naive patients","score":0.7960000038146973},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.8388011455535889},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8336074948310852},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6438291072845459},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6201299428939819},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5927764177322388},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5926518440246582},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.5619755387306213},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.47812214493751526},{"id":"https://openalex.org/C2909524832","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Basal insulin","level":4,"score":0.43416863679885864},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3416312038898468},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3263227939605713},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012648","descriptor_name":"Self Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.13822","doi":"https://doi.org/10.1111/dom.13822","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13822","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13822","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5828694","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6852247","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6852247","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6852247","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:31264764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31264764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1111/dom.13822","doi":"https://doi.org/10.1111/dom.13822","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13822","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13822","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320320870","display_name":"European Foundation for the Study of Diabetes","ror":"https://ror.org/05tgz4m05"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2955865129.pdf","grobid_xml":"https://content.openalex.org/works/W2955865129.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1965832529","https://openalex.org/W1971556813","https://openalex.org/W1973030309","https://openalex.org/W1978154080","https://openalex.org/W2026902135","https://openalex.org/W2032739316","https://openalex.org/W2036486575","https://openalex.org/W2103692362","https://openalex.org/W2114938391","https://openalex.org/W2121918915","https://openalex.org/W2122596924","https://openalex.org/W2123177035","https://openalex.org/W2126838326","https://openalex.org/W2135935030","https://openalex.org/W2140451842","https://openalex.org/W2265009211","https://openalex.org/W2587568247","https://openalex.org/W2594451671","https://openalex.org/W2837141746","https://openalex.org/W2894993577","https://openalex.org/W2895533920","https://openalex.org/W4247704066"],"related_works":["https://openalex.org/W2952194083","https://openalex.org/W3130741557","https://openalex.org/W2093684597","https://openalex.org/W3035226953","https://openalex.org/W1978154080","https://openalex.org/W2810565297","https://openalex.org/W2808821258","https://openalex.org/W2809616195","https://openalex.org/W2922463754","https://openalex.org/W2031080401"],"abstract_inverted_index":{"AIMS:":[0],"We":[1,50],"evaluated":[2],"risk":[3],"factors":[4],"for":[5,262],"clinically":[6],"relevant":[7,77],"hypoglycaemia":[8,78,132,156,192,219,244],"(blood":[9],"glucose":[10],"<3":[11],"mmol/L)":[12],"in":[13,29,127,163,205,210],"patients":[14,31,143,171,224,226,263],"with":[15,68,144,207,264],"type":[16,265],"2":[17,266],"diabetes":[18],"during":[19,193,248],"insulin":[20,41,109],"glargine":[21,42],"self-titration.":[22],"Data":[23],"were":[24,32,123,246],"from":[25,59],"two":[26,62],"clinical":[27],"trials":[28],"which":[30],"able":[33],"to":[34,161,179],"improve":[35],"glycaemic":[36,235],"control":[37],"by":[38,81,100],"self-titration":[39,260],"of":[40,55,61,83,102,131,155,174,191,218,234,240,259],"using":[43,228],"a":[44,150,186],"simple":[45],"algorithm.":[46],"MATERIALS":[47],"AND":[48],"METHODS:":[49],"performed":[51],"post":[52,212],"hoc":[53],"analyses":[54],"pooled":[56],"treatment":[57],"groups":[58],"each":[60],"Phase":[63],"3":[64],"studies":[65],"comparing":[66],"LY2963016":[67],"LANTUS:":[69],"ELEMENT-2":[70,117],"(double-blind)":[71],"and":[72,93,99,107,153,189,201,216,225,250],"ELEMENT-5":[73,138],"(open":[74],"label).":[75],"Clinically":[76],"was":[79,220],"analysed":[80],"category":[82],"HbA1c":[84,134,145,166,211],"(<7%,":[85],"7%-8.5%,":[86],">8.5%)":[87],"at":[88,94],"Week":[89,95],"12":[90],"(titration":[91],"period)":[92],"24":[96],"(overall":[97],"study),":[98],"subgroups":[101],"age":[103,175],"(<65,":[104],"\u226565":[105],"years)":[106],"previous":[108],"use":[110,258],"(na\u00efve":[111],"or":[112,129,176],"not).":[113],"RESULTS:":[114],"In":[115,136,168],"the":[116,137,158,164,194,238,241],"study":[118,139,159],"(N":[119,140],"=":[120,141],"756),":[121],"there":[122],"no":[124,208],"overall":[125],"differences":[126,209],"rate":[128,152,188,215],"incidence":[130,154,190,217],"among":[133],"categories.":[135,167],"493),":[142],"greater":[146],"than":[147,182],"8.5%":[148],"had":[149,185,197],"lower":[151,165,198],"throughout":[157],"compared":[160,178],"those":[162,180],"both":[169],"studies,":[170],"65":[172,183],"years":[173],"older,":[177],"less":[181],"years,":[184],"higher":[187],"titration":[195,249],"phase,":[196],"baseline":[199],"HbA1c,":[200],"experienced":[202],"smaller":[203],"increases":[204],"dose,":[206],"baseline.":[213],"The":[214],"similar":[221,247],"between":[222],"na\u00efve":[223],"previously":[227],"basal":[229],"insulin,":[230],"across":[231],"all":[232],"levels":[233],"control.":[236],"With":[237],"exception":[239],"older":[242],"subgroup,":[243],"rates":[245],"maintenance":[251],"periods.":[252],"CONCLUSION:":[253],"Our":[254],"results":[255],"support":[256],"broader":[257],"algorithms":[261],"diabetes.":[267]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-07-12T00:00:00"}